Short Interest in YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Decreases By 56.7%

YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) saw a significant decrease in short interest in the month of August. As of August 14th, there was short interest totaling 67,120 shares, a decrease of 56.7% from the July 30th total of 154,895 shares. Based on an average daily volume of 111,339 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.9% of the company’s stock are short sold.

YieldMax MRNA Option Income Strategy ETF Price Performance

MRNY traded up $0.49 during trading on Monday, hitting $33.11. 242,005 shares of the company traded hands, compared to its average volume of 238,116. YieldMax MRNA Option Income Strategy ETF has a one year low of $13.60 and a one year high of $42.39. The stock’s fifty day moving average is $19.81 and its 200 day moving average is $18.44.

YieldMax MRNA Option Income Strategy ETF Company Profile

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.